chr6-32040216-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000500.9(CYP21A2):​c.939+11G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00765 in 1,609,538 control chromosomes in the GnomAD database, including 371 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0083 ( 38 hom., cov: 33)
Exomes 𝑓: 0.0076 ( 333 hom. )

Consequence

CYP21A2
NM_000500.9 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.61

Publications

3 publications found
Variant links:
Genes affected
CYP21A2 (HGNC:2600): (cytochrome P450 family 21 subfamily A member 2) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
CYP21A2 Gene-Disease associations (from GenCC):
  • classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Laboratory for Molecular Medicine
  • classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 6-32040216-G-C is Benign according to our data. Variant chr6-32040216-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 256303.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0846 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000500.9. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP21A2
NM_000500.9
MANE Select
c.939+11G>C
intron
N/ANP_000491.4
CYP21A2
NM_001128590.4
c.849+11G>C
intron
N/ANP_001122062.3P08686-2
CYP21A2
NM_001368143.2
c.534+11G>C
intron
N/ANP_001355072.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP21A2
ENST00000644719.2
MANE Select
c.939+11G>C
intron
N/AENSP00000496625.1P08686-1
CYP21A2
ENST00000960600.1
c.975+11G>C
intron
N/AENSP00000630659.1
CYP21A2
ENST00000960597.1
c.948+11G>C
intron
N/AENSP00000630656.1

Frequencies

GnomAD3 genomes
AF:
0.00834
AC:
1259
AN:
150870
Hom.:
38
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00162
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00912
Gnomad ASJ
AF:
0.000868
Gnomad EAS
AF:
0.0909
Gnomad SAS
AF:
0.00608
Gnomad FIN
AF:
0.0259
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00400
Gnomad OTH
AF:
0.00727
GnomAD2 exomes
AF:
0.0144
AC:
3548
AN:
246188
AF XY:
0.0131
show subpopulations
Gnomad AFR exome
AF:
0.00146
Gnomad AMR exome
AF:
0.0209
Gnomad ASJ exome
AF:
0.00160
Gnomad EAS exome
AF:
0.0896
Gnomad FIN exome
AF:
0.0226
Gnomad NFE exome
AF:
0.00398
Gnomad OTH exome
AF:
0.00858
GnomAD4 exome
AF:
0.00758
AC:
11054
AN:
1458554
Hom.:
333
Cov.:
38
AF XY:
0.00748
AC XY:
5425
AN XY:
725624
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00108
AC:
36
AN:
33444
American (AMR)
AF:
0.0146
AC:
647
AN:
44226
Ashkenazi Jewish (ASJ)
AF:
0.000881
AC:
23
AN:
26120
East Asian (EAS)
AF:
0.108
AC:
4251
AN:
39410
South Asian (SAS)
AF:
0.00463
AC:
398
AN:
86028
European-Finnish (FIN)
AF:
0.0199
AC:
1041
AN:
52266
Middle Eastern (MID)
AF:
0.00574
AC:
33
AN:
5750
European-Non Finnish (NFE)
AF:
0.00373
AC:
4149
AN:
1111064
Other (OTH)
AF:
0.00790
AC:
476
AN:
60246
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.347
Heterozygous variant carriers
0
472
944
1417
1889
2361
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
218
436
654
872
1090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00833
AC:
1257
AN:
150984
Hom.:
38
Cov.:
33
AF XY:
0.00949
AC XY:
700
AN XY:
73770
show subpopulations
African (AFR)
AF:
0.00161
AC:
66
AN:
40934
American (AMR)
AF:
0.00904
AC:
137
AN:
15148
Ashkenazi Jewish (ASJ)
AF:
0.000868
AC:
3
AN:
3456
East Asian (EAS)
AF:
0.0915
AC:
465
AN:
5082
South Asian (SAS)
AF:
0.00587
AC:
28
AN:
4766
European-Finnish (FIN)
AF:
0.0259
AC:
272
AN:
10518
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00398
AC:
270
AN:
67792
Other (OTH)
AF:
0.00720
AC:
15
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.401
Heterozygous variant carriers
0
58
116
174
232
290
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00525
Hom.:
0
Bravo
AF:
0.00731

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not specified (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
15
DANN
Benign
0.66
PhyloP100
1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6442; hg19: chr6-32007993; API